<DOC>
	<DOCNO>NCT01026636</DOCNO>
	<brief_summary>This study ass pharmacokinetics ( drug absorb , distribute body removed time ) safety single dose ceftobiprole pediatric patient undergo treatment systemic antibiotic may use guide dose recommendation ceftobiprole child .</brief_summary>
	<brief_title>A Single-Dose Pharmacokinetics Safety Study Ceftobiprole Pediatric Patients =3 Months &lt; 18 Years Age</brief_title>
	<detailed_description>This purpose study ass pharmacokinetics ( drug absorb , distribute body removed time ) safety single dose ceftobiprole pediatric patient undergo treatment systemic antibiotic may use guide dose recommendation ceftobiprole child . This study open-label ( patient know identity drug ) single-dose , pharmacokinetic study infant child =3 month &lt; 18 year age medically stable judged clinical investigator require therapy antibiotic . Patients give 2-hour i.v . infusion ( give directly vein ) 7 , 10 , 15 mg/kg ceftobiprole . The study population group accord follow 4 age group : =12 &lt; 18 year age ; =6 &lt; 12 year age ; =2 &lt; 6 year age ; =3 month &lt; 2 year age . Every attempt make include patient sexes age group . Safety evaluation include clinical laboratory test ( hematology , serum chemistry , urinalysis ) , pregnancy testing , vital sign , physical examination , monitor adverse event , record concomitant medication . Patients give single 2-hour i.v . ( give directly vein ) infusion ceftobiprole . The total duration study approximately 18 day , include screen posttreatment .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Skin Diseases , Infectious</mesh_term>
	<mesh_term>Staphylococcal Skin Infections</mesh_term>
	<mesh_term>Streptococcal Infections</mesh_term>
	<mesh_term>Ceftobiprole</mesh_term>
	<mesh_term>Ceftobiprole medocaril</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>Infants ( =3 month &lt; 2 year age ) must bear =36 week gestation Documented presume , risk , bacterial infection ( ) receive systemic antibiotic therapy Stable medical condition History drug allergy hypersensitivity ÃŸlactam antibiotic penicillin , cephalosporin , carbapenems History clinically significant cardiac arrhythmia , cystic fibrosis , chronic lung disease associate abnormal pulmonary function , acute chronic arthritis History infection hepatitis B , hepatitis C , human immunodeficiency virus ( HIV )</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Staphylococcal Skin Infections</keyword>
	<keyword>Skin Infections</keyword>
	<keyword>Streptococcal Infections</keyword>
</DOC>